O'Keefe Stevens Advisory, Inc.

Position in BMY — Bristol Myers Squibb Co

CIK 1780565 ROCHESTER, NY

Position in BMY

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$240,275

-$12,635 QoQ

Shares Held

4,170

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#2,021

of 2,506 holders

Holding Since

Dec 2023

8 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

O'Keefe Stevens Advisory, Inc. holds $22,405,602 across 6 Drug Manufacturers - General names. BMY ranks #5 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	51,752	$18,740,434
2	PFE	Pfizer Inc	80,568	$1,940,077
3	JNJ	Johnson & Johnson	3,712	$942,736
4	MRK	Merck & Co., Inc.	2,544	$326,904
5	BMY	Bristol Myers Squibb Co This page	4,170	$240,275
6	NVS	Novartis AG	1,373	$215,176

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$240,275	4,170	0.0%	Shares	Sole	2026-07-13
2026-03-31	$252,910	4,170	0.0%	Shares	Sole	2026-04-07
2025-12-31	$224,929	4,170	-10.0%	Shares	Sole	2026-01-08
2025-03-31	$282,505	4,632	+1.4%	Shares	Sole	2025-04-09
2024-12-31	$258,479	4,570	0.0%	Shares	Sole	2025-01-15
2024-09-30	$236,451	4,570	0.0%	Shares	Sole	2024-10-08
2024-03-31	$247,831	4,570	0.0%	Shares	Sole	2024-04-11
2023-12-31	$234,486	4,570	—	Shares	Sole	2024-01-05
No filing history on record for this holder in this stock.